2m 2m 2m 2m 2m 2m 2m
Neogen (NEOG)
NASDAQ
$8.83-$0.005 (-0.06%)
Price as of Jun 23, 2026 5:03 PM EDT- $1.9BMarket Cap
- 87.00%1-Year Change
- Medical DevicesIndustry
Neogen (NEOG)
$8.83-$0.005 (-0.06%)
Annual
Quarterly
05/31/2025 | 05/31/2024 | 05/31/2023 | 05/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 797.3M -13.73% | 924.2M +12.37% | 822.4M +56.01% | 527.2M +12.53% | |
Cost of Revenue | 411.5M -10.61% | 460.3M +10.52% | 416.5M +46.58% | 284.1M +12.13% | |
Gross Profit | 421.4M -9.17% | 463.9M +14.27% | 406.0M +67.05% | 243.0M +13.00% | |
Sales and Marketing Expense | 183.8M +0.51% | 182.9M +29.49% | 141.2M +66.92% | 84.6M +15.20% | |
Research and Development Expense | -21.1M -6.18% | -22.5M -13.68% | -26.0M +52.73% | -17.0M +4.94% | |
Depreciation and Amortization Expense | 119.5M +2.37% | 116.7M +32.07% | 88.4M +272.99% | 23.7M +12.61% | |
Total Operating Expenses | 1.5B +265.80% | 405.2M +9.99% | 368.4M +99.81% | 184.4M +30.88% | |
Operating Profit | -1.1B -1,908.63% | 58.7M +56.37% | 37.5M -36.00% | 58.6M -20.97% | |
Interest Income | 3.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -71.6M -2.41% | -73.4M +31.15% | -56.0M N/A | N/A N/A | |
Interest Income and Expense and Net | -68.5M -6.65% | -73.4M +31.15% | -56.0M N/A | 0 N/A | |
Total Nonoperating Income and Expense | -72.1M -1.17% | -73.0M +22.52% | -59.6M -3,848.08% | 1.6M +44.59% | |
Income before Taxes | -1.1B +7,821.08% | -14.3M -35.10% | -22.0M -136.61% | 60.2M -20.01% | |
Income Taxes | -41.1M +740.83% | -4.9M -689.86% | 828,000 -93.04% | 11.9M -17.28% | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.1B +11,491.59% | -9.4M -58.81% | -22.9M -147.34% | 48.3M -20.65% | |
Net Income from Continuing Operations Applicable to Common | -1.1B +7,821.08% | -14.3M -35.10% | -22.0M -136.61% | 60.2M -20.01% | |
Basic EPS and Net Income | -5.03 +12,475.00% | -0.04 -66.67% | -0.12 -126.67% | 0.45 -21.05% | |
Diluted EPS and Net Income | -5.03 +12,475.00% | -0.04 -66.67% | -0.12 -126.67% | 0.45 -21.05% | |
Basic Weighted Average Shares | 216.9M +0.19% | 216.5M +14.61% | 188.9M +75.40% | 107.7M +1.11% | |
Diluted Weighted Average Shares | 216.9M +0.19% | 216.5M +14.61% | 188.9M +74.86% | 108.0M +0.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 129.0M -24.39% | 170.6M +4.52% | 163.2M +267.05% | 44.5M -41.17% | |
Short-Term Investments | 0 -100.00% | 325,000 -99.61% | 82.3M -75.54% | 336.6M +10.18% | |
Cash and Cash Equivalents and Short-Term Investments | 129.0M -24.53% | 170.9M -30.39% | 245.6M -35.55% | 381.1M -0.009% | |
Total Current Assets | 576.9M -2.09% | 589.2M +0.56% | 585.9M -6.52% | 626.8M +5.98% | |
Accumulated Depreciation | 155.4M +10.79% | 140.3M +16.79% | 120.1M +14.53% | 104.9M +7.22% | |
Property and Plant and Equipment and Net | 339.1M +22.38% | 277.1M +39.42% | 198.7M +79.73% | 110.6M +10.09% | |
Total Long-Term Assets | 35.2M +72.47% | 20.4M +34.20% | 15.2M +605.94% | 2.2M +6.79% | |
Total Assets | 3.4B -24.29% | 4.5B -0.12% | 4.6B +358.69% | 992.9M +7.90% | |
Income Taxes Payable | 286.5M -15.03% | 337.2M -6.44% | 360.4M +1,783.15% | 19.1M -19.47% | |
Total Short-Term Debt | 19.3M -97.87% | 904.9M N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 174.0M +12.76% | 154.3M +6.08% | 145.5M +86.88% | 77.8M +45.23% | |
Total Long-Term Debt | 874.8M -1.53% | 888.4M +0.33% | 885.4M N/A | N/A N/A | |
Total Long-Term Liabilities | 42.9M +21.54% | 35.3M -1.72% | 35.9M +235.30% | 10.7M +148.90% | |
Total Liabilities | 1.4B -2.29% | 1.4B -1.09% | 1.4B +1,245.47% | 105.6M +32.25% | |
Retained Earnings | -536.4M -196.55% | 555.6M -1.67% | 565.0M -3.89% | 587.9M +8.95% | |
Total Stockholders Equity | 2.1B -34.12% | 3.1B +0.32% | 3.1B +253.20% | 887.4M +5.59% | |
Total Shares Outstanding | 216.6M 0.00% | 216.6M +0.17% | 216.2M +100.60% | 107.8M +0.31% | |
Cash Flow | |||||
Cash from Operating Activities | 58.2M +65.17% | 35.3M -14.05% | 41.0M -39.70% | 68.0M -16.09% | |
Capital Expenditures | 104.6M -6.13% | 111.4M +69.44% | 65.8M +169.18% | 24.4M -8.55% | |
Cash from Investing Activities | -99.2M +238.45% | -29.3M -114.58% | 201.0M +306.77% | -97.2M -7.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.6M -183.32% | 1.9M +101.62% | -118.1M -1,833.17% | 6.8M -79.69% | |
Financials Ratio | |||||
Gross Margin | 48.39% -3.58% | 50.19% +1.69% | 49.36% +7.07% | 46.10% +0.42% | |
Operating Margin | -133.07% -2,196.50% | 6.35% +39.15% | 4.56% -58.98% | 11.12% -29.77% | |
Return on Assets | -27.33% +13,101.01% | -0.21% -74.89% | -0.82% -116.33% | 5.05% -28.77% | |
Return on Equity | -41.88% +13,854.58% | -0.30% -73.62% | -1.14% -120.34% | 5.59% -28.10% | |
Revenue Growth | -13.73% -210.96% | 12.37% -77.91% | 56.02% +347.03% | 12.53% +4.19% | |
Current Ratio | 3.32 -13.17% | 3.82 -5.20% | 4.03 -49.98% | 8.05 -27.03% | |
Cash Ratio | 0.74 -32.94% | 1.11 -1.48% | 1.12 +96.41% | 0.57 -59.50% | |
Debt-to-Equity Ratio | 0.43 -24.32% | 0.57 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.26 -34.15% | 0.39 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow